Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzan Stelloo

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Elife|December 20, 2019
TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growthSander Al Palit, Daniel Vis, Suzan Stelloo, et al.
Genome Biology|May 9, 2025
Endometrial tumorigenesis involves epigenetic plasticity demarcating non-coding somatic mutations and 3D-genome alterationsSebastian Gregoricchio, Aleksandar Kojic, Marlous Hoogstraat, et al.
Molecular Oncology|May 30, 2018
Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migrationBianca Cioni, Ekaterina Nevedomskaya, Monique H M Melis, et al.
European Urology|June 4, 2023
Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor-driven ProgramsSimon Linder, Tesa M Severson, Koen J C van der Mijn, et al.
Nature Communications|November 23, 2018
Integrative epigenetic taxonomy of primary prostate cancerSuzan Stelloo, Ekaterina Nevedomskaya, Yongsoo Kim, et al.
Cell Reports|March 7, 2025
PRC1 and PRC2 proximal interactome in mouse embryonic stem cellsDick W Zijlmans, Suzan Stelloo, Danique Bax, et al.
Cancer Research|June 5, 2013
Loss of p120-catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signalingRon C J Schackmann, Sjoerd Klarenbeek, Eva J Vlug, et al.
Cancer Cell|April 2, 2019
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate TumorigenesisMichael A Augello, Deli Liu, Lesa D Deonarine, et al.
The Journal of Biological Chemistry|September 22, 2023
Myeloid-derived suppressor cells and tolerogenic dendritic cells are distinctively induced by PI3K and Wnt signaling pathwaysGlenn F van Wigcheren, Jorge Cuenca-Escalona, Suzan Stelloo, et al.
Genome Research|May 8, 2024
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regionsStacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Elife|December 20, 2019
TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growthSander Al Palit, Daniel Vis, Suzan Stelloo, et al.
Genome Biology|May 9, 2025
Endometrial tumorigenesis involves epigenetic plasticity demarcating non-coding somatic mutations and 3D-genome alterationsSebastian Gregoricchio, Aleksandar Kojic, Marlous Hoogstraat, et al.
Molecular Oncology|May 30, 2018
Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migrationBianca Cioni, Ekaterina Nevedomskaya, Monique H M Melis, et al.
European Urology|June 4, 2023
Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor-driven ProgramsSimon Linder, Tesa M Severson, Koen J C van der Mijn, et al.
Nature Communications|November 23, 2018
Integrative epigenetic taxonomy of primary prostate cancerSuzan Stelloo, Ekaterina Nevedomskaya, Yongsoo Kim, et al.
Cell Reports|March 7, 2025
PRC1 and PRC2 proximal interactome in mouse embryonic stem cellsDick W Zijlmans, Suzan Stelloo, Danique Bax, et al.
Cancer Research|June 5, 2013
Loss of p120-catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signalingRon C J Schackmann, Sjoerd Klarenbeek, Eva J Vlug, et al.
Cancer Cell|April 2, 2019
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate TumorigenesisMichael A Augello, Deli Liu, Lesa D Deonarine, et al.
The Journal of Biological Chemistry|September 22, 2023
Myeloid-derived suppressor cells and tolerogenic dendritic cells are distinctively induced by PI3K and Wnt signaling pathwaysGlenn F van Wigcheren, Jorge Cuenca-Escalona, Suzan Stelloo, et al.
Genome Research|May 8, 2024
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regionsStacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, et al.
Pageof 3